Akero Therapeutics
AcquiredUnited States · $135.0M raised
- Website
- akerotx.com
- Total Funding
- $135.0M
- Last Round
- $70.0M Series BDec 2018
- Rounds
- 2
About
Akero Therapeutics is a clinical stage biotechnology company developing novel therapies for patients with non-alcoholic steatohepatitis.
Summary
Akero Therapeutics is a Life Sciences company based in United States. It has raised $135.0M in total across 2 rounds, most recently a $70.0M Series B round in Dec 2018. Investors include Novo Nordisk and Apple.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
BridgeBio makes targeted treatments for genetic diseases.